既往局灶治疗对挽救性机器人辅助根治性前列腺切除术围手术期、肿瘤学和功能结局的影响
该回顾性匹配配对研究比较了22例局灶治疗失败后行挽救性机器人辅助根治性前列腺切除术与44例初次机器人辅助根治性前列腺切除术患者的结局。两组并发症率相当(p>0.05),1年和2年无尿垫概率相当(p=0.8);挽救组勃起功能恢复显著更低(p=0.008),2年累积生化复发无生存概率显著更低(56.3% vs 92.4%,p=0.001),生化复发风险显著增加(HR 4.8,95%CI 1.67-13.76,p=0.004)。作者认为挽救性手术可行且并发症率可接受,但应告知局灶治疗患者未来挽救手术肿瘤控制更差且勃起恢复率更低。
要点
- 挽救性机器人辅助根治性前列腺切除术后并发症率与初次手术相当(p>0.05)。
- 挽救组勃起功能恢复显著低于初次组(p=0.008)。
- 挽救组2年无生化复发生存率56.3% vs 初次组92.4%(p=0.001),生化复发风险HR 4.8(95%CI 1.67-13.76,p=0.004)。
核心结论
- 局灶治疗失败后行挽救性机器人辅助根治性前列腺切除术可行且并发症率可接受,但肿瘤控制和勃起恢复不如初次手术。
- 接受初次局灶治疗的患者应被告知未来若需挽救手术,预后更差且勃起恢复率更低。
研究设计与样本
- 回顾性匹配配对研究,挽救组22例局灶治疗失败后行挽救性机器人辅助根治性前列腺切除术,初次组从2750例初次机器人辅助根治性前列腺切除术患者中按1:2匹配选取44例。
- 局灶治疗入选标准为Gleason评分3+3或3+4、临床分期cT2a或以下、血清前列腺特异抗原15 ng/ml或以下、单侧活检阳性、任一阳性针芯最大长度小于10 mm、预期寿命大于10年。
- 局灶治疗定义为靶向消融索引病灶加同侧正常前列腺实质1 cm安全边缘。
主要发现
- 两组并发症率相当(p>0.05)。
- 1年和2年无尿垫概率两组相当(p=0.8)。
- 挽救性机器人辅助根治性前列腺切除术后勃起功能恢复显著更低(p=0.008)。
- 挽救组2年累积生化复发无生存概率显著低于初次组(56.3% vs 92.4%,p=0.001)。
- 挽救性前列腺切除术后生化复发风险显著增加(HR 4.8,95%CI 1.67-13.76,p=0.004)。
临床怎么用
- 作者认为局灶治疗失败后行挽救性机器人辅助根治性前列腺切除术可行且并发症率可接受。
- 作者建议应告知接受初次局灶治疗的患者,未来若需挽救手术,肿瘤控制预后更差且勃起恢复率更低。
局限性
- 研究为回顾性。
- 缺乏随机化。
- 随访时间短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed the impact of focal therapy on perioperative, oncologic and functional outcomes in men who underwent salvage robotic assisted radical prostatectomy compared to primary robotic assisted radical prostatectomy. MATERIALS AND METHODS: Focal therapy was performed in patients presenting with Gleason score 3 + 3 or 3 + 4, clinical stage cT2a or less, serum prostate specific antigen 15 ng/ml or less, unilateral positive biopsy, maximum length of any positive core less than 10 mm and life expectancy greater than 10 years. Focal therapy was defined as target ablation of the index lesion plus a 1 cm safety margin in the normal ipsilateral prostatic parenchyma. The salvage group included 22 men who underwent salvage prostatectomy after focal therapy failure. The primary group was defined using matched pair 1:2 selection of 44 of 2,750 patients treated with primary prostatectomy. The primary and secondary end points were the between group differences in functional and oncologic outcomes, respectively. RESULTS: Complication rates were comparable (p >0.05). Pad-free probability was comparable between the groups at 1 and 2 years (p = 0.8). Recovery of erectile function was significantly lower after salvage robotic assisted radical prostatectomy (p = 0.008), which also showed a significantly lower probability of cumulative biochemical recurrence-free survival compared to primary robotic assisted radical prostatectomy (56.3% vs 92.4% at 2 years, p = 0.001). Salvage prostatectomy demonstrated a significantly increased risk of biochemical recurrence (HR 4.8, 95% CI 1.67-13.76, p = 0.004). Study limitations included the retrospective nature, the lack of randomization and the short followup. CONCLUSIONS: Salvage robotic assisted radical prostatectomy after focal therapy failure is feasible with acceptable complication rates. However, patients assigned to primary focal therapy should be advised about a poorer prognosis in terms of oncologic control and lower erectile recovery rates in case of a future salvage surgery.
引用
- Nunes-Silva I, Barret E, Srougi V, et al. Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy. J Urol. 2017. PMID: 28551444. doi:10.1016/j.juro.2017.05.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。